Podocyte ACE2 protects against diabetic nephropathy.
Level V
Where this comes from
- Record sourced from PubMed, PMID 22791320.
- Also identified by DOI 10.1038/ki.2012.127 and PMC identifier 7112297.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
As new components of the renin-angiotensin system (RAS) are elucidated, our understanding of the complexities of their interactions also advances. Previous studies have determined that podocytes possess a local RAS that can generate angiotensin II. Podocytes have also been shown to express angiotensin-converting enzyme 2 (ACE2), which can decrease angiotensin II levels by generation of angiotensin-(1-7). Nadarajah et al. now show that increased podocyte ACE2 activity can attenuate the development of diabetic nephropathy.
Medical subject headings
- Diabetic Nephropathies
- Peptidyl-Dipeptidase A
- Podocytes